Home Diseases and Conditions

Diseases and Conditions

Densely packed cannabis plants under LED lights at large scale industrial growing operation.

Visualizing the anti-inflammatory cannabinoid Type-2 receptor

Medicinal chemists describe how small molecule probes allow for the detection of CB2R, and thereby enable the discovery of novel anti-inflammatory treatments.
Allergic asthma

Allergic asthma and the legacy of structural racism on the African American urban communities

Allergic asthma is a chronic inflammatory disease characterized by bronchial hyperactivity, disproportionately affecting African Americans.
Trans-sectoral approaches,

Trans-sectorial approaches sustainable disease control across agribusiness districts

Professor Laura Grenville-Briggs shares her stance on working together to counter the threat of oomycete diseases, focussing on trans-sectoral approaches to support sustainable plant and fish production systems in Europe.
cannais plants

Challenges bringing CB₂R medicine to bedside

Drug hunters explain how to overcome pitfalls on the way to CB2R medicine and therapeutics.
treatment for inflammatory bowel disease

Prebiotics from algae as a treatment for inflammatory bowel disease

The Algae4IBD project is studying the potential of probiotics and algae-derived prebiotics as a treatment for inflammatory bowel disease.

Wicked-Schisto: The wicked public health problem of Schistosomiasis and the interdisciplinary research helping to...

Poppy Lamberton, Professor of Global Health at the University of Glasgow, is leading an interdisciplinary team aiming to identify cost-effective, sustainable interventions for schistosomiasis, a devastating neglected tropical disease.

Whole-person integrative oncology – A path to improved outcomes and patient empowerment

Integrative oncology gives patients the tools to not only make the environment as inhospitable to cancer as possible – it also empowers patients to take some control back after receiving a cancer diagnosis.
Disease surveillance SACIDS image

Enhancing community-based disease surveillance using Afyadata in Mozambique

SACIDS, in collaboration with the Ministry of Health in Mozambique is capitalizing on its AfyaData, a digital disease surveillance app, to enhance early detection, timely reporting and prompt feedback/response to health-related signals/events, including COVID-19 and other priority diseases in the country.

Remyelinating versus neuroprotective therapies for multiple sclerosis

Reducing clinical relapses and improving quality of life is at the heart of MS treatment; here Tara M. DeSilva explores the benefits of remyelinating versus neuroprotective therapies for tackling MS.
woman in COVID mask

Long Covid lessons: beyond winter and the COVID pandemic

Paying attention to Long Covid lessons is key: Long Covid has already provided lessons for other long-term conditions and planning for future pandemics far beyond COVID-19.
Hydra in the sea

Understanding Hydra Regeneration

Here, Charisios Tsiairis from Friedrich Miescher Institute for Biomedical Research explores Hydra Regeneration and the genetic programs that make it possible.
tumor cells

Killing cancer softly: The resolution of cancer lies in tumor cells

Dr Dipak Panigrahy, M.D., an Assistant Professor at Harvard Medical School looks at killing tumor cells to resolve the cancer epidemic.
memory decline

Alzheimer’s drug slows memory decline in phase 3 trial

Henry Scowcroft from Alzheimer’s Research UK, argues that an Alzheimer’s drug, lecanemab, can slow memory decline in a phase 3 trial.
abstract image: Doctor and AI, individualized metabolomics

Managing chronic disease with individualized metabolomics & artificial intelligence

Christopher Gerner from the Joint Metabolome Facility at the University of Vienna, Austria, walks us through what we need to know about managing chronic disease by individualized metabolomics & artificial intelligence.
woman injecting tuberculosis drug

Tuberculosis drug regimens and their efficacies

Andrew Nunn, Professor of Epidemiology in the Medical Research Council Clinical Trials Unit at UCL, analyses tuberculosis drug development.
cannabis to treat diseases

Is CB₂R a hidden treasure trove for treating inflammatory diseases?

Expert scientists working on endocannabinoid system (ECS) trials explain how CB₂R can be used to treat inflammatory diseases.
tick borne diseases

Tick-borne Diseases Transmission Research: Co-Feeding in Ticks

Tick-borne diseases such as Lyme disease and tick-borne encephalitis are primarily transmitted during the blood feeding process, through systemic and co-feeding horizontal transmission routes.
wearing a surgical mask, awaiting treatment for her mother for tuberculosis at a local clinic.

Treatment decision algorithms for childhood tuberculosis

James Seddon, Reader in Global Child Health at Imperial College London, discusses the development of treatment decision algorithms for childhood tuberculosis.

Neurodegeneration in multiple sclerosis: retinal imaging as a biomarker

Therapeutic strategies for multiple sclerosis reduce the number of relapses and improve quality of life early in the disease course, nevertheless, neurodegeneration ultimately gives rise to permanent disability.

A Bluetooth tracking device to aid the search for older people with dementia who...

Getting lost can affect caregivers and families of older people with dementia – now, a Bluetooth tracking device can assist the search for their...

Follow Open Access Government